Cargando…

Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives

INTRODUCTION: The exceptional production of research evidence during the COVID-19 pandemic required deployment of scientists to act in advisory roles to aid policy-makers in making evidence-informed decisions. The unprecedented breadth, scale and duration of the pandemic provides an opportunity to u...

Descripción completa

Detalles Bibliográficos
Autores principales: Vickery, Jamie, Atkinson, Paul, Lin, Leesa, Rubin, Olivier, Upshur, Ross, Yeoh, Eng-Kiong, Boyer, Chris, Errett, Nicole A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023846/
https://www.ncbi.nlm.nih.gov/pubmed/35450862
http://dx.doi.org/10.1136/bmjgh-2021-008268
_version_ 1784690428629483520
author Vickery, Jamie
Atkinson, Paul
Lin, Leesa
Rubin, Olivier
Upshur, Ross
Yeoh, Eng-Kiong
Boyer, Chris
Errett, Nicole A
author_facet Vickery, Jamie
Atkinson, Paul
Lin, Leesa
Rubin, Olivier
Upshur, Ross
Yeoh, Eng-Kiong
Boyer, Chris
Errett, Nicole A
author_sort Vickery, Jamie
collection PubMed
description INTRODUCTION: The exceptional production of research evidence during the COVID-19 pandemic required deployment of scientists to act in advisory roles to aid policy-makers in making evidence-informed decisions. The unprecedented breadth, scale and duration of the pandemic provides an opportunity to understand how science advisors experience and mitigate challenges associated with insufficient, evolving and/or conflicting evidence to inform public health decision-making. OBJECTIVES: To explore critically the challenges for advising evidence-informed decision-making (EIDM) in pandemic contexts, particularly around non-pharmaceutical control measures, from the perspective of experts advising policy-makers during COVID-19 globally. METHODS: We conducted in-depth qualitative interviews with 27 scientific experts and advisors who are/were engaged in COVID-19 EIDM representing four WHO regions and 11 countries (Australia, Canada, Colombia, Denmark, Ghana, Hong Kong, Nigeria, Sweden, Uganda, UK, USA) from December 2020 to May 2021. Participants informed decision-making at various and multiple levels of governance, including local/city (n=3), state/provincial (n=8), federal or national (n=20), regional or international (n=3) and university-level advising (n=3). Following each interview, we conducted member checks with participants and thematically analysed interview data using NVivo for Mac software. RESULTS: Findings from this study indicate multiple overarching challenges to pandemic EIDM specific to interpretation and translation of evidence, including the speed and influx of new, evolving, and conflicting evidence; concerns about scientific integrity and misinterpretation of evidence; the limited capacity to assess and produce evidence, and adapting evidence from other contexts; multiple forms of evidence and perspectives needed for EIDM; the need to make decisions quickly and under conditions of uncertainty; and a lack of transparency in how decisions are made and applied. CONCLUSIONS: Findings suggest the urgent need for global EIDM guidance that countries can adapt for in-country decisions as well as coordinated global response to future pandemics.
format Online
Article
Text
id pubmed-9023846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90238462022-04-22 Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives Vickery, Jamie Atkinson, Paul Lin, Leesa Rubin, Olivier Upshur, Ross Yeoh, Eng-Kiong Boyer, Chris Errett, Nicole A BMJ Glob Health Original Research INTRODUCTION: The exceptional production of research evidence during the COVID-19 pandemic required deployment of scientists to act in advisory roles to aid policy-makers in making evidence-informed decisions. The unprecedented breadth, scale and duration of the pandemic provides an opportunity to understand how science advisors experience and mitigate challenges associated with insufficient, evolving and/or conflicting evidence to inform public health decision-making. OBJECTIVES: To explore critically the challenges for advising evidence-informed decision-making (EIDM) in pandemic contexts, particularly around non-pharmaceutical control measures, from the perspective of experts advising policy-makers during COVID-19 globally. METHODS: We conducted in-depth qualitative interviews with 27 scientific experts and advisors who are/were engaged in COVID-19 EIDM representing four WHO regions and 11 countries (Australia, Canada, Colombia, Denmark, Ghana, Hong Kong, Nigeria, Sweden, Uganda, UK, USA) from December 2020 to May 2021. Participants informed decision-making at various and multiple levels of governance, including local/city (n=3), state/provincial (n=8), federal or national (n=20), regional or international (n=3) and university-level advising (n=3). Following each interview, we conducted member checks with participants and thematically analysed interview data using NVivo for Mac software. RESULTS: Findings from this study indicate multiple overarching challenges to pandemic EIDM specific to interpretation and translation of evidence, including the speed and influx of new, evolving, and conflicting evidence; concerns about scientific integrity and misinterpretation of evidence; the limited capacity to assess and produce evidence, and adapting evidence from other contexts; multiple forms of evidence and perspectives needed for EIDM; the need to make decisions quickly and under conditions of uncertainty; and a lack of transparency in how decisions are made and applied. CONCLUSIONS: Findings suggest the urgent need for global EIDM guidance that countries can adapt for in-country decisions as well as coordinated global response to future pandemics. BMJ Publishing Group 2022-04-21 /pmc/articles/PMC9023846/ /pubmed/35450862 http://dx.doi.org/10.1136/bmjgh-2021-008268 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Vickery, Jamie
Atkinson, Paul
Lin, Leesa
Rubin, Olivier
Upshur, Ross
Yeoh, Eng-Kiong
Boyer, Chris
Errett, Nicole A
Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title_full Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title_fullStr Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title_full_unstemmed Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title_short Challenges to evidence-informed decision-making in the context of pandemics: qualitative study of COVID-19 policy advisor perspectives
title_sort challenges to evidence-informed decision-making in the context of pandemics: qualitative study of covid-19 policy advisor perspectives
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023846/
https://www.ncbi.nlm.nih.gov/pubmed/35450862
http://dx.doi.org/10.1136/bmjgh-2021-008268
work_keys_str_mv AT vickeryjamie challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT atkinsonpaul challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT linleesa challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT rubinolivier challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT upshurross challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT yeohengkiong challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT boyerchris challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives
AT errettnicolea challengestoevidenceinformeddecisionmakinginthecontextofpandemicsqualitativestudyofcovid19policyadvisorperspectives